Sinequan 25mg Capsules

Manufacturer PFIZER U.S. Active Ingredient Doxepin Capsules(DOKS e pin) Pronunciation DOKS-e-pin
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.It is used to treat anxiety.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antidepressant, Anxiolytic, Hypnotic
đŸ§Ŧ
Pharmacologic Class
Tricyclic Antidepressant (TCA)
🤰
Pregnancy Category
Category C
✅
FDA Approved
Jun 1969
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Doxepin is a medication used to treat depression and anxiety. It belongs to a class of drugs called tricyclic antidepressants. It works by affecting certain natural chemicals in the brain that help regulate mood. At lower doses, it can also be used to help with sleep problems (insomnia).
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, it's essential to follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. If you're taking this medication once a day, take it at bedtime. Continue taking your medication as directed by your doctor or healthcare provider, even if you're feeling well.

Storing and Disposing of Your Medication

To maintain the effectiveness and safety of your medication, store it at room temperature, protected from light, and in a dry place. Avoid storing it in a bathroom. Keep all medications in a secure location, out of the reach of children and pets. When disposing of unused or expired medication, do not flush it down the toilet or pour it down the drain unless instructed to do so by your pharmacist. Instead, check with your pharmacist for guidance on the best disposal method or explore local drug take-back programs.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
💡

Lifestyle & Tips

  • Avoid alcohol and other sedating medications, as doxepin can increase drowsiness and dizziness.
  • Be cautious when driving or operating machinery until you know how this medication affects you.
  • Do not stop taking this medication suddenly, as it can cause withdrawal symptoms. Your doctor will guide you on how to slowly reduce the dose if needed.
  • Report any new or worsening symptoms, especially changes in mood, behavior, or thoughts of self-harm, to your doctor immediately.
  • Manage common side effects like dry mouth (sugar-free candy/gum, sips of water) and constipation (increase fiber and fluids).

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: For depression/anxiety: Initially 25-50 mg/day, titrate up to 75-150 mg/day. For insomnia (low dose formulation, e.g., Silenor): 3-6 mg at bedtime.
Dose Range: 25 - 300 mg

Condition-Specific Dosing:

Depression/Anxiety: 75-150 mg/day, maximum 300 mg/day. Doses above 150 mg/day should be given in divided doses.
Insomnia (low dose): 3-6 mg once daily at bedtime (for Silenor formulation, not Sinequan 25mg capsules).
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: For depression/anxiety (off-label, with caution): 10-25 mg/day initially, titrate up to 100-150 mg/day. Not first-line due to Black Box Warning.
Adolescent: For depression/anxiety (off-label, with caution): 10-25 mg/day initially, titrate up to 100-150 mg/day. Not first-line due to Black Box Warning.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment needed.
Moderate: No specific adjustment needed, but monitor for adverse effects.
Severe: Use with caution; consider lower doses and monitor for adverse effects due to potential accumulation of active metabolites.
Dialysis: Not significantly dialyzable. Use with caution, monitor for adverse effects.

Hepatic Impairment:

Mild: Use with caution.
Moderate: Reduce dose; consider starting at lower end of dosing range and titrate slowly.
Severe: Contraindicated or significantly reduced dose; monitor closely for toxicity.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Doxepin is a tricyclic antidepressant (TCA) that primarily inhibits the reuptake of norepinephrine and serotonin at the presynaptic neuronal membrane, thereby increasing their concentrations in the synaptic cleft. It also possesses potent antagonism at histamine H1 receptors, moderate antagonism at serotonin (5-HT2) and alpha-1 adrenergic receptors, and weak anticholinergic (muscarinic) activity. Its sedative effects are largely attributed to H1 antagonism, while antidepressant effects are linked to monoamine reuptake inhibition.
📊

Pharmacokinetics

Absorption:

Bioavailability: Variable (due to extensive first-pass metabolism), approximately 13-45%
Tmax: 2-4 hours (doxepin), 2-10 hours (desmethyldoxepin)
FoodEffect: Food may delay Tmax but does not significantly affect AUC.

Distribution:

Vd: 9-33 L/kg (large volume of distribution)
ProteinBinding: >90%
CnssPenetration: Yes

Elimination:

HalfLife: Doxepin: 8-24 hours; Desmethyldoxepin: 28-52 hours
Clearance: Not available (highly variable due to first-pass)
ExcretionRoute: Renal (primarily as metabolites)
Unchanged: <5%
âąī¸

Pharmacodynamics

OnsetOfAction: Sedative effects: within hours; Antidepressant effects: 2-4 weeks
PeakEffect: Antidepressant effects: 4-6 weeks
DurationOfAction: 24 hours (due to long half-life of active metabolite)

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of doxepin or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber.
âš ī¸

Side Effects

Serious Side Effects: Seek Medical Attention Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical help right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high or low blood pressure, including:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
Fast heartbeat
Difficulty urinating
Feeling extremely nervous or excitable
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling very tired or weak
Yellowing of the skin or eyes (jaundice)
Ringing in the ears (tinnitus)
Changes in sex drive
Enlarged breasts or nipple discharge
Swelling of the testicles

Important Warning for Asthma Patients

If you have asthma, use this medication with caution. Some people with asthma have experienced worsening symptoms while taking this drug. If your asthma symptoms worsen, contact your doctor right away.

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. Contact your doctor or seek medical help if you experience any of the following side effects or if they persist or bother you:

Dizziness, drowsiness, tiredness, or weakness
Constipation, diarrhea, stomach pain, upset stomach, vomiting, or decreased appetite
Dry mouth
Changes in taste
Mouth irritation or mouth sores
Weight gain
Excessive sweating
Flushing
Hair loss
* Headache

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Thoughts of suicide or self-harm
  • Worsening depression or anxiety
  • New or worsening agitation, restlessness, panic attacks, irritability, aggressiveness, impulsivity
  • Unusual changes in behavior or mood (e.g., hypomania, mania)
  • Severe dizziness or fainting spells (orthostatic hypotension)
  • Fast, pounding, or irregular heartbeat
  • Difficulty urinating
  • Severe constipation or abdominal pain
  • Blurred vision or eye pain
  • Fever, sore throat, or other signs of infection (rare, but indicates potential blood dyscrasias)
  • Yellowing of skin or eyes (jaundice)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced.
Certain health conditions, such as:
+ Difficulty urinating
+ Glaucoma
Current or recent use of specific medications, including:
+ Linezolid or methylene blue
+ Certain antidepressants or Parkinson's disease medications taken within the last 14 days, including isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline (as this may lead to very high blood pressure)
Use of other medications that can cause drowsiness, as there are many drugs with this potential effect. If you are unsure, consult your doctor or pharmacist.
* If you are breastfeeding, as you should not breastfeed while taking this medication.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Before engaging in activities that require your full attention, such as driving, wait until you understand how this drug affects you.

Please note that it may take several weeks to experience the full effects of this medication. Do not abruptly stop taking this drug without consulting your doctor, as this may increase your risk of side effects. If you need to discontinue this medication, your doctor will guide you on how to gradually stop taking it to minimize potential risks.

While taking this medication, it is recommended that you avoid consuming alcohol. Additionally, before using marijuana, other forms of cannabis, or prescription or over-the-counter (OTC) drugs that may cause drowsiness, consult with your doctor.

Some individuals may have a higher risk of developing eye problems while taking this medication. Your doctor may recommend an eye exam to assess your risk. If you experience eye pain, changes in vision, or swelling and redness in or around the eye, contact your doctor immediately.

This medication may increase your sensitivity to the sun, making you more prone to sunburn. Take necessary precautions when exposed to sunlight, and inform your doctor if you experience frequent sunburns while taking this medication.

If you have diabetes (high blood sugar), it is crucial to closely monitor your blood sugar levels. Be aware of signs of high or low blood sugar, such as fruity-smelling breath, dizziness, rapid breathing, rapid heartbeat, confusion, sleepiness, weakness, flushing, headache, unusual thirst or hunger, frequent urination, shaking, or sweating. If you experience any of these symptoms, notify your doctor.

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.

Some medications, including this one, may affect fertility and the ability to conceive. If you have concerns or questions, discuss them with your doctor.

If you are pregnant or planning to become pregnant, consult with your doctor to weigh the benefits and risks of taking this medication during pregnancy. Taking this drug in the third trimester may lead to health problems in the newborn, so it is essential to discuss this with your doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Severe drowsiness or coma
  • Confusion, disorientation, hallucinations
  • Severe dry mouth, blurred vision, dilated pupils
  • Fast, irregular, or pounding heartbeat (tachycardia, arrhythmias, QT prolongation)
  • Low blood pressure (hypotension)
  • Seizures
  • Respiratory depression
  • Urinary retention
  • Hypothermia
  • Hyperreflexia or muscle rigidity

What to Do:

Seek immediate emergency medical attention. Call 911 or your local emergency number. For poison control, call 1-800-222-1222. Treatment is supportive and symptomatic, including gastric lavage, activated charcoal, and monitoring of cardiac function (ECG) and vital signs. Physostigmine may be used for severe anticholinergic toxicity, but with caution due to cardiac risks.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) - concurrent use or within 14 days of MAOI discontinuation (risk of serotonin syndrome, hyperpyrexic crisis, severe convulsions, and death)
  • Cisapride (risk of QT prolongation and arrhythmias)
🔴

Major Interactions

  • CNS Depressants (e.g., alcohol, benzodiazepines, opioids, sedatives, hypnotics, antihistamines) - additive CNS depression
  • Anticholinergic Agents (e.g., atropine, scopolamine, benztropine, some antipsychotics) - additive anticholinergic effects (dry mouth, blurred vision, urinary retention, constipation, confusion)
  • Sympathomimetic Agents (e.g., epinephrine, norepinephrine, phenylephrine) - potentiated cardiovascular effects (hypertension, arrhythmias)
  • CYP2D6 Inhibitors (e.g., fluoxetine, paroxetine, quinidine, cimetidine) - increased doxepin plasma concentrations and toxicity risk
  • QT-prolonging Drugs (e.g., antiarrhythmics, certain antipsychotics, macrolide antibiotics) - increased risk of QT prolongation and Torsades de Pointes
  • Thyroid Hormones - increased risk of cardiac arrhythmias and other adverse effects
🟡

Moderate Interactions

  • Cimetidine - inhibits doxepin metabolism, leading to increased plasma levels
  • Barbiturates - may decrease doxepin plasma levels due to enzyme induction
  • Oral Contraceptives - may alter doxepin metabolism
  • Warfarin - potential for altered anticoagulant effect (monitor INR)
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Electrocardiogram (ECG)

Rationale: To assess for pre-existing cardiac conduction abnormalities or risk factors for QT prolongation, especially in elderly patients or those with cardiac disease.

Timing: Prior to initiation

Liver Function Tests (LFTs)

Rationale: Doxepin is extensively metabolized by the liver; to assess baseline hepatic function.

Timing: Prior to initiation

Renal Function Tests (e.g., BUN, Creatinine)

Rationale: To assess baseline renal function, especially in patients with pre-existing renal impairment.

Timing: Prior to initiation

Complete Blood Count (CBC)

Rationale: Rare reports of bone marrow depression (agranulocytosis, leukopenia, eosinophilia, thrombocytopenia).

Timing: Prior to initiation

Suicidal Ideation/Behavior Assessment

Rationale: To establish baseline and identify risk, especially in children, adolescents, and young adults.

Timing: Prior to initiation

📊

Routine Monitoring

Clinical Response and Adverse Effects

Frequency: Weekly during initial titration, then periodically (e.g., monthly) or as clinically indicated

Target: Improvement in target symptoms (e.g., mood, anxiety, sleep) with tolerable side effects.

Action Threshold: Worsening symptoms, emergence of new symptoms, or intolerable side effects warrant dose adjustment or discontinuation.

Suicidal Ideation/Behavior

Frequency: Especially during initial treatment (first few months) and dose changes, then periodically

Target: Absence of suicidal thoughts or behaviors.

Action Threshold: Emergence or worsening of suicidal ideation, agitation, or unusual changes in behavior requires immediate clinical assessment and intervention.

Blood Pressure (especially orthostatic)

Frequency: Periodically, especially during initial titration and in elderly patients

Target: Stable blood pressure, absence of orthostatic hypotension.

Action Threshold: Significant orthostatic drops (e.g., >20 mmHg systolic, >10 mmHg diastolic) or symptomatic hypotension requires dose adjustment or intervention.

Anticholinergic Side Effects (e.g., dry mouth, constipation, urinary retention, blurred vision)

Frequency: Routinely inquire at each visit

Target: Minimal or tolerable side effects.

Action Threshold: Severe or bothersome anticholinergic effects may require dose reduction, adjunctive treatment, or change in therapy.

Plasma Doxepin/Desmethyldoxepin Levels (Therapeutic Drug Monitoring)

Frequency: As clinically indicated (e.g., non-response, suspected toxicity, drug interactions, adherence concerns)

Target: Combined plasma levels of doxepin and desmethyldoxepin: 100-250 ng/mL (for depression/anxiety)

Action Threshold: Levels outside therapeutic range may warrant dose adjustment.

đŸ‘ī¸

Symptom Monitoring

  • Worsening depression
  • Emergence of suicidal thoughts or behavior
  • Unusual changes in behavior (e.g., agitation, irritability, hostility, impulsivity, akathisia, hypomania, mania)
  • Sedation/drowsiness
  • Dizziness/lightheadedness (especially upon standing)
  • Dry mouth
  • Blurred vision
  • Constipation
  • Urinary retention
  • Confusion or cognitive impairment (especially in elderly)
  • Cardiac symptoms (e.g., palpitations, chest pain, syncope)

Special Patient Groups

🤰

Pregnancy

Category C. Doxepin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Neonatal withdrawal symptoms (e.g., respiratory distress, cyanosis, apnea, seizures, feeding difficulties, hypotonia, hypertonia, tremor, irritability, prolonged crying) have been reported in neonates exposed to TCAs during the third trimester.

Trimester-Specific Risks:

First Trimester: Limited data, but generally considered low risk for major malformations based on overall TCA data. However, animal studies show some adverse effects.
Second Trimester: Not well-studied, but generally considered safer than first or third trimester.
Third Trimester: Risk of neonatal withdrawal syndrome, respiratory distress, and other adverse effects. Monitor neonate closely if exposed.
🤱

Lactation

Doxepin and its active metabolite are excreted into breast milk. The American Academy of Pediatrics considers doxepin to be a drug for which the effect on the nursing infant is unknown but may be of concern. Monitor infants for sedation, poor feeding, and poor weight gain. Use with caution, or consider alternative agents, especially in preterm or neonates.

Infant Risk: L3 (Moderately Safe) - Potential for infant sedation, poor feeding, and irritability. Monitor infant closely.
đŸ‘ļ

Pediatric Use

Doxepin is not FDA-approved for depression or anxiety in pediatric patients. A Black Box Warning exists regarding increased risk of suicidal thoughts and behavior in children, adolescents, and young adults (up to 24 years of age) treated with antidepressants. Use with extreme caution and close monitoring if prescribed off-label.

👴

Geriatric Use

Elderly patients are more sensitive to the anticholinergic, sedative, and hypotensive effects of doxepin. They are also at increased risk for falls, cognitive impairment, and cardiac conduction abnormalities. Start with lower doses (e.g., 10-25 mg/day) and titrate slowly. Avoid if possible in patients with dementia or significant cardiovascular disease.

Clinical Information

💎

Clinical Pearls

  • Doxepin has significant anticholinergic and sedative properties, which can be beneficial for insomnia or anxiety with agitation, but problematic for other patients.
  • Orthostatic hypotension is a common side effect, especially in the elderly; advise patients to rise slowly from sitting or lying positions.
  • Cardiac conduction abnormalities (e.g., QT prolongation, arrhythmias) can occur, particularly at higher doses or in patients with pre-existing cardiac disease. ECG monitoring may be warranted.
  • Abrupt discontinuation can lead to withdrawal symptoms (e.g., nausea, vomiting, dizziness, headache, irritability, sleep disturbance); taper dose gradually.
  • Therapeutic drug monitoring (TDM) for doxepin and desmethyldoxepin levels can be useful in cases of non-response, suspected toxicity, or drug interactions.
  • Due to its potent H1 antagonism, low-dose doxepin (3-6 mg) is specifically approved for insomnia (Silenor brand) and should not be confused with the higher doses used for depression/anxiety.
🔄

Alternative Therapies

  • Other Tricyclic Antidepressants (TCAs): Amitriptyline, Imipramine, Nortriptyline
  • Selective Serotonin Reuptake Inhibitors (SSRIs): Fluoxetine, Sertraline, Paroxetine, Citalopram, Escitalopram
  • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): Venlafaxine, Duloxetine
  • Atypical Antidepressants: Bupropion, Mirtazapine, Trazodone
  • Benzodiazepines (for anxiety, short-term use): Alprazolam, Lorazepam, Diazepam
  • Non-benzodiazepine hypnotics (for insomnia): Zolpidem, Eszopiclone, Zaleplon
💰

Cost & Coverage

Average Cost: Varies, typically $10-$50 per 30 capsules (25mg generic)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (for generic formulations)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe and effective treatment, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, a patient fact sheet that provides crucial information. It is essential to read this guide carefully and review it again each time your prescription is refilled. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider for guidance.

In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide detailed information, including the name of the medication taken, the quantity, and the time it occurred.